Cold or Hot Snare Endoscopic Mucosal Resection for 10-19mm Non-pedunculated Colorectal Polyps

April 30, 2026 updated by: Qingwei Jiang

A Prospective, Randomized, Non-inferiority Study to Compare Efficacy and Safety of Cold Snare Endoscopic Mucosal Resection and Hot Snare Endoscopic Mucosal Resection in Treatment for 10-19 mm Non-pedunculated Colorectal Polyps

This is a prospective, randomized, open-label, non-inferiority, multiple-center trial. Outpatients who are scheduled to undergo colonoscopy and found eligible polyps will be randomized to receive either cold snare endoscopic mucosal resection (CS-EMR) or hot snare endoscopic mucosal resection (HS-EMR). This study aims to compare the efficacy and safety of CS-EMR or HS-EMR for the resection of non-pedunculated colorectal polyps sized 10-19mm.

Study Overview

Study Type

Interventional

Enrollment (Actual)

216

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 102218
        • Beijing Tsinghua Changgung Hospital
      • Beijing, Beijing Municipality, China, 100730
        • Peking Union Medical College Hospital
      • Beijing, Beijing Municipality, China, 100028
        • Emergency General Hospital
      • Beijing, Beijing Municipality, China, 100010
        • Beijing Dongcheng District First People's Hospital
      • Beijing, Beijing Municipality, China, 100191
        • Beijing Sixth Hospital
      • Beijing, Beijing Municipality, China, 100700
        • Seventh Medical Center, General Hospital of the Chinese People's Liberation Army
      • Beijing, Beijing Municipality, China, 102401
        • Beijing Fangshan District Liangxiang Hospital
      • Beijing, Beijing Municipality, China, 102600
        • Beijing Daxing District People'S Hospital
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, China, 400016
        • The First Affiliated Hospital of Chongqing Medical University
    • Henan
      • Zhengzhou, Henan, China, 450003
        • Henan Provincial People's Hospital
    • Jiangxi
      • Nanchang, Jiangxi, China, 330006
        • The First Affiliated Hospital of Nanchang University
    • Shandong
      • Qingdao, Shandong, China, 266005
        • The Affiliated Hospital of Qingdao University
    • Shanxi
      • Taiyuan, Shanxi, China, 030001
        • The First Hospital of Shanxi Medical University
    • Sichuan
      • Chengdu, Sichuan, China, 610041
        • West China Longquan Hospital, Sichuan University
      • Chengdu, Sichuan, China, 610083
        • PLA Western Theater General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18-80 years of age;
  • undergo colonoscopy in the Digestive Endoscopy Center of Peking Union Medical College Hospital, Beijing Tsinghua Changgung Hospital or Seventh Medical Center, General Hospital of the Chinese People's Liberation Army;
  • volunteer to participate in this study and sign informed consent;
  • at least one polyp sized 10-19 mm (Paris classification Is or IIa) by colonoscopy.

Exclusion Criteria:

  • American Society of Anesthesiologists (ASA) status class 3 or above;
  • poor bowel preparation (Boston bowel preparation scale < 6 points);
  • known or endoscopic features indicating the submucous infiltration or malignancy;
  • oral anti-coagulants, or antiplatelet agents, or known blood coagulation disorders, or bleeding tendency (platelets<50000 cells/mm3 or INR>1.5);
  • a history of colorectal resection;
  • emergency colonoscopy (hemodynamic instability and/or continued active gastrointestinal bleeding and/or requiring intensive care patients);
  • inflammatory bowel disease, familial polyposis, and colorectal cancer;
  • pregnancy or lactation;
  • severe cardiopulmonary dysfunction, liver cirrhosis, chronic kidney disease, other malignant tumors, or severe infectious diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cold snare endoscopic mucosal resection (CS-EMR)
Eligible colorectal polyps sized 10-19mm will be resected by CS-EMR
During CS-EMR, methylene blue-tinted epinephrine saline will be injected into the submucosal space around the lesion to lift the lesion. The polyp and 1-2mm of surrounding mucosa will then be closely snared and transected mechanically.
Experimental: Hot snare endoscopic mucosal resection (HS-EMR)
Eligible colorectal polyps sized 10-19mm will be resected by HS-EMR
During HS-EMR, methylene blue-tinted epinephrine saline will be injected into the submucosal space around the lesion to lift the lesion. The snare will be placed around the lesion, and then cautery will be applied using the electrosurgical generator.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complete resection rate
Time Frame: Within 14 days
The resection is considered histologically complete if the lateral margins of the resected polyps are surrounded by normal tissue and the vertical margin is free of neoplasia tissue. If en-bloc resection is not achieved, 5 biopsies (4 biopsies obtained in a 4-quadrant fashion from the polypectomy site margins; 1 biopsy from the base) are applied to evaluate histological completeness of resection.
Within 14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
En-bloc resection rate
Time Frame: Within 1 day
The lesion was completely excised under endoscope and a single specimen was obtained.
Within 1 day
Intraprocedural bleeding
Time Frame: Within 1 day
Any immediate episode requiring any form of endoscopic hemostasis or oozing for more than 60s
Within 1 day
Intraprocedural perforation
Time Frame: Within 1 day
Endoscopic observation of perforation requiring sealing with clips
Within 1 day
Delayed bleeding
Time Frame: Within 14 days
Any episode requiring emergency department presentation, hospitalization, or reintervention within 14 days
Within 14 days
Delayed perforation
Time Frame: Within 14 days
Any perforation within 14 days
Within 14 days
Number of clips used
Time Frame: Within 1 day
The number of endoscopic clips used for each resected polyp
Within 1 day
Resection time
Time Frame: Within 1 day
The duration from the first occurrence of injection needle under endoscope visual field to complete removal of the resected polyp
Within 1 day
Total cost
Time Frame: Within 1 day
Total cost including both treatment cost and material cost for polyp resection
Within 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Qingwei Jiang, MD, Peking Union Medical College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2022

Primary Completion (Actual)

April 15, 2026

Study Completion (Actual)

April 15, 2026

Study Registration Dates

First Submitted

September 15, 2022

First Submitted That Met QC Criteria

September 15, 2022

First Posted (Actual)

September 19, 2022

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 30, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • K2203

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Polyp

Clinical Trials on Cold snare endoscopic mucosal resection

Subscribe